Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) [Trend Analysis] knocking active thrust in leading trading session, shares a gain of 2.35% to 2.61 with about 103926 shares have changed hands in this session. Idera Pharmaceuticals, Inc. (IDRA) released that it aims to offer and sell up to $50,000,000 of shares of its ordinary stock in an underwritten public offering.
In connection with this offering, Idera expects to grant the underwriters a 30-day option to purchase additional shares of ordinary stock, equal to up to 15% of the number of shares of ordinary stock sold in the offering. All of the shares in the offering are to be sold by Idera. Idera intends to use the net proceeds from this offering, together with existing cash, cash equivalents and investments, to advance clinical development of certain of its programs. J.P. Morgan and Goldman, Sachs & Co. are acting as joint bookrunning managers for the offering. The stock is going forward its fifty-two week low with 119.33% and lagging behind from its 52-week high price with -40.95%.
Same, the positive performance for the quarter recorded as 57.41% and for the year was -9.57%, while the YTD performance remained at -17.48%. IDRA has Average True Range for 14 days of 0.21.
Shares of AT&T, Inc. (NYSE:T) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease of -2.54% to close at $38.88. AT&T has gone from a regional phone firm to a national telecommunications powerhouse over the last decade. Its next big expansion will see it buying businesses to transform into a media and entertainment giant, according to people familiar with the plans. David Kirkpatrick, Techonomy’s chief executive officer, and Bloomberg’s Gerry Smith react on “Bloomberg Technology.” Moving forward to saw long-term intention, the experts calculate Return on Investment of 7.10%. The stock is going forward its fifty-two week low with 25.24% and lagging behind from its 52-week high price with -10.64%. T last month stock price volatility remained 1.60%.